DOSIsoft Overview

  • Founded
  • 2002
  • Status
  • Private
  • Employees
  • 30
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $510K
Latest Deal Amount
  • Investors
  • 1

DOSIsoft General Information


Developer of software to optimize cancer-treatment technology and imaging. The company creates software designed to optimize radiotherapy planning tools and medical imaging. It offers software platforms for contouring (IMAgo), virtual simulation (SIMAgo) and dose planning (ISOgray).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Other Industries
Vertical Market Software
Other Healthcare Technology Systems
Primary Office
  • 45/47, avenue Carnot
  • 94230 Cachan
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DOSIsoft Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 15-Mar-2011 $510K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2002 Completed Startup
To view DOSIsoft’s complete valuation and funding history, request access »

DOSIsoft Executive Team (1)

Name Title Board Seat Contact Info
Hanna Kafrouni Ph.D Chief Executive Officer
To view DOSIsoft’s complete executive team members history, request access »

DOSIsoft Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DOSIsoft Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IncubAlliance Accelerator/Incubator 000 0000 000000 0
To view DOSIsoft’s complete investors history, request access »